Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior ....

Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) Date: 09th August, 2026 The Deputy Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub: Prior Intimation of Board Meeting to be held on Thursday, 13th August, 2026 under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref: Scrip Code: 586565 Scrip Id: NOVELIX Respected Sir/Madam, Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 13th August, 2026 at the Registered office of the Company, inter-alia to discuss the following: 1. To Consider and Approve the unaudited standalone financial results for the quarter ended on June 30, 2026 along with limited review report of the auditors. 2. Any other matter with the permission of chair. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and Company's "Code of Conduct for Prevention of Insider Trading" the Trading Window for the Designated Persons and their immediate relatives is closed from July 01, 2026 till forty-eight hours after the conclusion of the aforesaid meeting of the Board of Directors. We request you to take the aforesaid information on record for dissemination through your website. Thanking You, Yours faithfully, For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com